Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
TLK199.2102 was a multicenter Phase 2 randomized study to determine the effect of Telintra
treatment on chemotherapy induced neutropenia (CIN) in patients with non small cell lung
cancer receiving first-line therapy with carboplatin and docetaxel.